NCT06733389

Brief Summary

Pulse pressure variation (PPV) and pleth variability index (PVI) are widely used in clinical practice as indicators of the responsiveness to fluid therapy in patients receiving mechanical ventilation. PPV, which measures changes in arterial pressure, requires arterial puncture, which is invasive, and PVI, which detects subtle changes in oxygen saturation, requires an expensive, commercial monitoring equipment. In this study, we aimed to measure peripheral venous pressure variation using less invasive waveform variation in peripheral veins and to determine whether this indicator can be clinically used to predict the responsiveness to fluid therapy. In addition, the investigators aimed to confirm the superiority of the indicators by comparing them with the responsiveness to fluid therapy of the PPV and PVI.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2024Nov 2026

First Submitted

Initial submission to the registry

December 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

December 28, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2026

Expected
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

December 10, 2024

Last Update Submit

December 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fluid responsiveness

    Cardiac output increases by more than 15% after 250 mL crystalloid injection during a fluid challenge

    intraoperative period

Study Arms (1)

peripheral waveform collection group

1. Peripheral Venous Pressure Variation 2. Pulse Pressure Variation 3. Pleth Variability Index

Other: peripheral waveform collection

Interventions

The peripheral venous pressure is collected by connecting a pressure transducer that is currently in use to the central venous line. In addition, pulse pressure variation and stroke volume variation that can be obtained from the arterial catheter. In addition, the pleth variability index is collected through the oxygen saturation monitoring. This extracts the medical records and bio-signal information of the subjects registered through the previously approved 'Establishment of a Bio-signal and Clinical Information Registry for the Development of Patient Monitoring Algorithms' (B-2202-738-401).

peripheral waveform collection group

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for elective hepatectomy under general anesthesia

You may qualify if:

  • Patients voluntarily agreed and signed the written informed consent form before participating in the study
  • Adults aged 19 years or older
  • American Society of Anesthesiologists physical class (ASA) 1-3
  • Patients scheduled for elective hepatectomy under general anesthesia
  • Patients who require arterial pressure monitoring and additional peripheral venous access for routine anesthesia preparation
  • Non-smokers with normal pulmonary function

You may not qualify if:

  • Patients with abnormal findings on electrocardiogram before surgery
  • Patients who cannot undergo peripheral venous puncture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyunggi-do, 13620, South Korea

Location

Study Officials

  • Insun Park

    assistant professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Insun Park, M.D./Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 10, 2024

First Posted

December 13, 2024

Study Start

December 28, 2024

Primary Completion

November 28, 2025

Study Completion (Estimated)

November 28, 2026

Last Updated

December 17, 2024

Record last verified: 2024-12

Locations